IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence

Clinical trial NCT07495124 · RECRUITING

Trial details

NCT number: NCT07495124
Sponsor: University of Washington
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Fallopian Tube Carcinoma Ovarian Carcinoma Primary Peritoneal Carcinoma

Start date: 2026-09-01
Primary completion: 2027-09-29
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.